T1	Treatment 11 35	CCND1 A870G polymorphism
T2	Treatment 113 151	adjuvant concurrent chemoradiotherapy]
T3	Treatment 369 426	capecitabine-based postoperative chemoradiotherapy (CRT).
T4	Treatment 516 563	CRT of capecitabine with or without oxaliplatin
T5	Treatment 730 780	concurrent capecitabine and radiotherapy (Cap-CRT)
T6	Treatment 817 878	capecitabine and oxaliplatin plus radiotherapy (Cap-Oxa-CRT).
T7	Treatment 2073 2084	Cap-Oxa-CRT
T8	Treatment 2259 2266	Cap-CRT
T9	Treatment 2375 2386	CCND1 A870G
T10	Treatment 2513 2583	adjuvant concurrent chemoradiotherapy of capecitabine and oxaliplatin.
